IQVIA Holdings is gearing up to release its third-quarter earnings later this month, and analysts project a steady ...

Shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) are trading higher Thursday after the Florida-based pharmaceutical company ...

Fintel reports that on October 9, 2025, HSBC upgraded their outlook for IQVIA Holdings (NYSE:IQV) from Hold to Buy. Analyst ...

Fintel reports that on October 8, 2025, Evercore ISI Group maintained coverage of IQVIA Holdings (NYSE:IQV) with a Outperform ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund’s Investor ...

On October 2, 2025, GSK and IQVIA announced a major update to their Vaccine Track data tool, expanding local-level coverage ...

Broyhill Asset Management, an investment advisor, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Broyhill Partners appreciated 3.7% net of all fees and ...

IQVIA Holdings Inc. closed 13.26% below its 52-week high of $237.21, which the company reached on October 18th.

According to Benzinga Pro, IQVIA Holdings Inc's peer group average for short interest as a percentage of float is 7.75%, which means the company has less short interest than most of its peers. Did you ...

Americans headed to pharmacies for COVID vaccines are running into roadblocks and confusion due to new U.S. guidance that ...

As the pharmaceutical industry moves beyond rule-based omnichannel marketing, a new era of agentic systems is emerging, in which AI-powered agents collaborate with humans to orchestrate engagement, ...

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is ...